DALI Apheresis in Hyperlipidemic Patients: Biocompatibility, Efficacy, and Selectivity of Direct Adsorption of Lipoproteins from Whole Blood
- 1 February 2000
- journal article
- research article
- Published by Wiley in Artificial Organs
- Vol. 24 (2) , 81-90
- https://doi.org/10.1046/j.1525-1594.2000.06476.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effects of lipid lowering therapy on progression of coronary and carotid artery diseaseCurrent Opinion in Lipidology, 1997
- LDL Hemoperfusion‐A New Procedure for LDL Apheresis: Biocompatibility Results from a First Pilot Study in Hypercholesterolemic Atherosclerosis PatientsArtificial Organs, 1997
- LDL Hemoperfusion‐A New Procedure for LDL Apheresis: First Clinical Application of an LDL Adsorber Compatible with Human Whole BloodArtificial Organs, 1997
- Current status of low density lipoprotein-apheresis for the therapy of severe hyperlipidemiaCurrent Opinion in Lipidology, 1996
- Lipid Apheresis: From a Heroic Treatment to Routine Clinical PracticeArtificial Organs, 1996
- State of the Art of Lipid ApheresisArtificial Organs, 1996
- Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible MechanismsNew England Journal of Medicine, 1995
- Lipid Apheresis by Hemoperfusion: In Vitro Efficacy and Ex Vivo Biocompatibility of a New Low‐Density Lipoprotein Adsorber Compatible with Human Whole BloodArtificial Organs, 1993
- Tissue Kallikrein of Human Seminal Plasma is Secreted by the Prostate GlandBiological Chemistry Hoppe-Seyler, 1985
- Disparity between surface and deep nephron function early after renal ischemiaKidney International, 1983